CombiGene publishes the prospectus for the rights issue

CombiGene AB (publ) (”CombiGene” or ”the Company”) publishes this prospectus pursuant to a resolution by the board of CombiGene AB on 22 August 2018 to introduce a preference issue of units (”the Issue”). Full subscription of the offer will generate about...

read more

Interim Report January – june 2018

Interim Report >> Combigene AB, Medicon Village, SE-223-81 Lund, Visiting adress: Scheelevägen 2, Lund, Sweden <a href="https://www.linkedin.com/company/10149155/" target="blank"><i class="fa fa-linkedin fa-3x"...

read more

CombiGene: New issue registered

CombiGene AB realized a preference share issue in February 2018. The issue raised 2.3 million kronor before issuing expenses. Read more >> Combigene AB, Medicon Village, SE-223-81 Lund, Visiting adress: Scheelevägen 2, Lund, Sweden <a...

read more

CombiGene AB publishes memorandum

CombiGene AB publishes this memorandum pursuant to a resolution by the board of CombiGene AB on 22 January to introduce a preference share issue which was authorized by the Annual General Meeting on 9 May 2017. The new issue is a preference share issue,...

read more

About CombiGene

CombiGene’s vision is to provide patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. Development assets are sourced from an external research network and developed to achieve clinical proof of concept. Drug candidates for common diseases will be co-developed and commercialized through strategic partnerships, while the company may manage this process on its own for drugs targeting niched patient populations. The company is public and listed on the Swedish marketplace Nasdaq First North Growth Market and the company’s Certified Advisor is FNCA Sweden AB, +46 (0)852 80 03 99 info@fnca.se.

 

Combigene AB, Medicon Village, SE-223-81 Lund, Visiting adress: Scheelevägen 2, Lund, Sweden

Linked In     Twitter      Facebook